Addex Therapeutics (ADXN) Other Non-Current Assets (2022 - 2024)
Historic Other Non-Current Assets for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to $8092.2.
- Addex Therapeutics' Other Non-Current Assets fell 8679.14% to $8092.2 in Q4 2024 from the same period last year, while for Dec 2024 it was $8092.2, marking a year-over-year decrease of 8679.14%. This contributed to the annual value of $8058.1 for FY2024, which is 8668.28% down from last year.
- Per Addex Therapeutics' latest filing, its Other Non-Current Assets stood at $8092.2 for Q4 2024, which was down 8679.14% from $904951.6 recorded in Q1 2024.
- In the past 5 years, Addex Therapeutics' Other Non-Current Assets ranged from a high of $904951.6 in Q1 2024 and a low of $8092.2 during Q4 2024
- For the 3-year period, Addex Therapeutics' Other Non-Current Assets averaged around $257682.6, with its median value being $58843.3 (2022).
- In the last 5 years, Addex Therapeutics' Other Non-Current Assets soared by 858.41% in 2023 and then plummeted by 8679.14% in 2024.
- Addex Therapeutics' Other Non-Current Assets (Quarter) stood at $56421.7 in 2022, then rose by 8.58% to $61265.0 in 2023, then tumbled by 86.79% to $8092.2 in 2024.
- Its Other Non-Current Assets stands at $8092.2 for Q4 2024, versus $904951.6 for Q1 2024 and $61265.0 for Q4 2023.